Roopmati, A 56–year–old female with lymph-node-positive breast cancer was treated with systemic chemotherapy. Four weeks later, she developed frequent urination, suprapubic pain, dysuria, and hematuria. Which of the following could have prevented this patient's condition?: (A) Folinic acid, (B) Mesna, (C) Dexrazoxane, (D) Amifostine
Answer is B. None